A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1993
12/23/1993	CA2138146A1 Proteinoid carriers and methods for preparation and use thereof
12/23/1993	CA2138010A1 Microparticles, method of producing them and their use for diagnostic purposes
12/23/1993	CA2137145A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications
12/23/1993	CA2135295A1 Arabinogalactan derivatives and uses thereof
12/22/1993	EP0575137A1 Oral composition containing carrier-bound antimicrobials
12/22/1993	EP0575054A2 Protein C derivatives
12/22/1993	EP0574638A1 Soluble dextran-glutathione complexes, method of preparing same and their use
12/22/1993	EP0574571A1 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
12/22/1993	EP0574504A1 Pharmaceutical preparations for the therapy of tumors containing colchicine as the active principle and methods for the use of the same
12/22/1993	EP0574395A1 Cytokine immunoconjugates
12/22/1993	EP0413016B1 Novel compositions containing hyaluronic acid associates and a process for preparing same
12/22/1993	CN1079757A Yeast debris products
12/22/1993	CN1079749A Toxins
12/22/1993	CN1023229C Stable mixture containing oxidation-sensitive compounds, its prepn. and application
12/21/1993	US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS)
12/21/1993	US5272253 Cluster conjugates of drugs with antibodies
12/21/1993	US5272135 Method for the stabilization of methionine-containing polypeptides
12/21/1993	US5271946 Controlled release azelastine-containing pharmaceutical compositions
12/21/1993	US5271941 Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases
12/21/1993	US5271928 Stable microbubbles suspensions injectable into living organisms
12/17/1993	CA2098474A1 Composition for treating pain, method for treating pain and composition for reinforcing pain relief action
12/16/1993	DE4219724A1 Verwendung von Mikrokapseln als Kontrastmittel für die Farbdoppler-Sonographie Use of the microcapsules as a contrast agent for the color Doppler ultrasonography
12/16/1993	DE4219723A1 Mikropartikel, Verfahren zu deren Herstellung, sowie die Verwendung dieser in der Diagnostik Microparticles, methods for their preparation, as well as the use of these in diagnostics
12/15/1993	EP0574221A1 Pharmaceutical stable formulations of nicorandil
12/15/1993	EP0573777A1 Oral pharmaceutical compositions containing anthocyanosides
12/15/1993	EP0573605A1 Preparation of factor ix
12/15/1993	EP0573423A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof
12/15/1993	EP0550737A4 Controlled release verapamil tablet
12/15/1993	EP0524963B1 Process for producing solid active substance forms and products so obtained
12/15/1993	EP0465550B1 Pharmaceutical lipid composition for parenteral nutrition
12/15/1993	EP0464171B1 Aerosol carriers
12/14/1993	US5270461 Benzoate esters of alkoxylated methyl glucosides
12/14/1993	US5270419 Polyanhydrides of oligomerized unsaturated aliphatic acids
12/14/1993	US5270379 Amine functional polymers as thickening agents
12/14/1993	US5270346 Penetration enhancers for transdermal delivery of systemic agents
12/14/1993	US5270337 Oxygen removal
12/14/1993	US5270199 Human mannose-binding protein
12/14/1993	US5270196 Arylsulfatase from streptomyces
12/14/1993	US5270171 Cancer-associated SCM-recognition factor, preparation and method of use
12/14/1993	US5270057 Salt of an organic acid
12/14/1993	US5270038 Tumor necrosis factor receptors on microorganisms
12/14/1993	US5270030 Fibrin binding domain polypeptide and method of producing
12/09/1993	WO1993024640A2 Methods and compositions for in vivo gene therapy
12/09/1993	WO1993024540A1 Rapid hydrolysis of cross-linked maleic anhydride/lower alkyl vinyl ether copolymers
12/09/1993	WO1993024476A1 Water-soluble polymeric carriers for drug delivery
12/09/1993	WO1993024154A1 Biodegradable controlled release melt-spun delivery system
12/09/1993	WO1993024150A1 Salts of peptides with carboxy-terminated polyesters
12/09/1993	WO1993024149A1 Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
12/09/1993	WO1993024148A1 Combined vaccines comprising hepatitis b surface antigen and other antigens
12/09/1993	WO1993024141A1 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material
12/09/1993	WO1993024129A1 Composition for treating acne vulgaris
12/09/1993	WO1993024124A1 Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
12/09/1993	WO1993024116A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993	WO1993024114A1 Reservoir-type plaster containing ketorolac
12/09/1993	WO1993024111A1 Oral decongestant product
12/09/1993	WO1993024109A1 Palatable pharmaceutical compositions
12/09/1993	DE4221269C1 Zubereitung zur topischen Anwendung Preparation for topical use
12/09/1993	CA2137268A1 Biodegradable controlled release melt-spun delivery system
12/09/1993	CA2136845A1 Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
12/09/1993	CA2136623A1 Compositions based on histamine h-2 receptor antagonists and cationic exchangers complexes
12/09/1993	CA2134773A1 Methods and compositions for in vivo gene therapy
12/09/1993	CA2113809A1 Pharmaceutical composition for the treatment of acne vulgaris
12/09/1993	CA2070724A1 Composite anesthetic article and method of use
12/08/1993	EP0573094A2 Absorbable blend for controlled release
12/08/1993	EP0572963A2 High efficacy sclerosing solution causing no iatrogenic lesions and process to obtain this solution
12/08/1993	EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments
12/08/1993	EP0572731A1 Chewable preparation containing a decongestant
12/08/1993	EP0572627A1 Solvent system to be enclosed in capsules.
12/08/1993	EP0572624A1 Lubricous polymer network
12/08/1993	EP0572573A1 Thyroid-derived chondrocyte-stimulating factor
12/08/1993	EP0572502A1 Polyamino acid dispersants
12/08/1993	EP0572494A1 Composition for use in transdermal administration
12/08/1993	EP0572486A1 Delayed release oral dosage forms for treatment of intestinal disorders.
12/08/1993	EP0572443A1 Suppression of immune responses with oligomeric forms of antigen of controlled chemistry
12/08/1993	EP0572429A1 Sulfonyl urea derivates, method for preparing them and use thereof
12/07/1993	US5268454 Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
12/07/1993	US5268371 Containing a radioactive metal
12/07/1993	US5268368 Cyclophosphamide--amino acid lyophilizates
12/07/1993	US5268364 Block addition of a serine or threonine residue to protein
12/07/1993	US5268287 Phosphazene polymer with hydrophilic side groups
12/07/1993	US5268181 Method of using niacin to control nocturnal cholesterol synthesis
12/07/1993	US5268180 Encapsulating aqueous phase
12/07/1993	US5268164 Intravascular administering a oligopeptide
12/07/1993	CA1324959C Stabilized anthracycline preparation
12/01/1993	EP0572190A1 Ophthalmic compositions containing vitamin E or ester thereof as an active ingredient
12/01/1993	EP0572049A2 Liposomes
12/01/1993	EP0571973A2 Slow-release sodium valproate tablets
12/01/1993	EP0571921A2 Cyclopeptides and their use as resorption enhancers in mucous use
12/01/1993	EP0571671A1 A Pharmaceutical composition in powder form
12/01/1993	EP0571575A1 Unbuffered premixed ranitidine formulation
12/01/1993	EP0571416A1 (carboxyl)alkyloxyalkyl derivatives of cyclodextrins
12/01/1993	EP0544900A4 Transdermal nicotine absorption dosage unit and process
12/01/1993	CN1078910A Biocompatible somatotropin solutions
11/1993
11/30/1993	US5266581 Solid composition containing dihydropyridine, PVP and PVPP
11/30/1993	US5266563 Hyakyribate-poly (ethylene oxide) mixtures
11/30/1993	US5266334 Sugar-free dry mix cellulose ether compositions as bulk laxatives
11/30/1993	US5266333 Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration of growth hormone
11/30/1993	US5266331 Controlled release oxycodone compositions
11/30/1993	US5266310 Stabilization of therapeutically active proteins in pharmaceutical preparations
11/30/1993	CA2097164A1 Slow-release sodium valproate tablets

1 ... 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 ... 1712